China Select Committee visits MA: The House Select Committee on the Chinese Communist Party recently conducted field hearings in Massachusetts to study biotech competition between China and the United States. Bio-manufacturing in places like Fall River, Norton, and Plainville in our district complement Greater Boston’s outsize contribution to R&D, driving the bioeconomy forward. The bio-economy is a big prize; the life sciences provide jobs, cures, and new applications in fields like agriculture and materials. I got to preview the trip with WPRI 12. You can watch it here.
The Committee wants to study how the U.S. should respond to China’s major investments in biotech. In my op-ed for the Boston Globe, I explain that Massachusetts shows us how: by supporting talented people; by passing policy that promotes makers, not takers; and by providing biotech infrastructure. Two steps in the right direction would be to fully appropriate the basic research provisions of the bipartisan CHIPS and Science Act, which would unlock more public money for science, and reverse the Trump-era amortization penalty on research and experimental expenditures, which would unlock more private money for science and which just passed the House, with my support.
The broader economic and technological competition between the U.S. and China has two core elements: getting tougher on trade with China while increasing U.S. investments at home and U.S. engagement with the Global South – countries like Indonesia, Nigeria, and Brazil. In a recent interview with Inside U.S. Trade, I argue that the House Select Committee on the Chinese Communist Party must convince Congress of both elements.
Milford Senior Center town hall: I visited with seniors at the Milford Senior Center, where we discussed border security and immigration reform, Ukraine aid, and health care in a Q&A session hosted by the senior center.
I also highlighted that, beginning this year, Medicare Part D beneficiaries, particularly those suffering from cancer, will start seeing lower out-of-pocket costs for their prescription drugs. Starting next year, there will be a hard cap of $2,000 for annual out-of-pocket costs in Part D, benefitting thousands of seniors in our district. These reductions are part of the 2022 legislation that empowered Medicare to negotiate drug prices; I am now working to lower this cap further through my own legislation.
Building opportunities with Consigli: I visited family-owned Consigli Construction, which has an impressive portfolio of Eds & Meds construction projects here in Massachusetts. I met with their leadership to share notes on healthcare and life sciences economic trends and to discuss political dynamics in Washington. Employers are seeking stability and competence in governance, so that they can make their own long-term decisions. As your Representative, I am committed to working across the aisle to pass needed legislation on healthcare, taxes, and foreign policy.
Honoring Black History Month with the Attleboro Council on Human Rights: I spoke at the Attleboro Arts Museum, where the Museum and the Attleboro Council on Human Rights teamed up for Black History Month to invite Black artists to reimagine Civil War artifacts through their own artwork. I was inspired by art that emphasized “our common humanity”, even in times of division and strife, in the words of one of the artists. I also particularly enjoyed Reverend Cheryl Harris’s speech on the role of song in Black history. |